In vitro study: binding of ^99mTc-DPD to synthetic amyloid fibrils

1. Ak I. et al.: Myocardial Tc-99m MDP uptake on a bone scan in senile systemic amyloidosis with cardiac involvement. Clin. Nucl. Med., 25, 10, 2000.10.1097/00003072-200010000-00019Search in Google Scholar

2. Aprile C. et al.: Accumulation of 99mTc-Sn Pyrophosphate in pleural effusion. Eur. J. Nucl. Med., 3, 4, 1978.10.1007/BF00251395Search in Google Scholar

3. Bokhari S. et al.: 99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ. Cardiovasc. Imaging, 6, 2, 2013.10.1161/CIRCIMAGING.112.000132Search in Google Scholar

4. Casset-Senon D. et al.: Localization of myocardial amyloid deposits in cardiac amyloidosis by Tc-99m pyrophosphate myocardial SPECT: implication for medical treatment. Clin. Nucl. Med., 30, 7, 2005.10.1097/01.rlu.0000167664.47995.d9Search in Google Scholar

5. Djokić D.D., Janković D.L., Nikolić N.S.: Labeling, characterization, and in vivo localization of a new 90Y-based phosphonate chelate 2,3-dicarboxypropane-1,1-diphosphonic acid for the treatment of bone metastases: Comparison with 99mTc-DPD complex. Bioorg. Med. Chem., 16, 8, 2008.Search in Google Scholar

6. Dubrey S.W. et al.: Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart, 78, 1, 1997.10.1136/hrt.78.1.74Search in Google Scholar

7. Falk R.: Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis. Am. J. Cardiol., 54, 8, 1984.10.1016/S0002-9149(84)80170-8Search in Google Scholar

8. Falk R. et al.: Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am. J. Cardiol., 51, 5, 1983.10.1016/S0002-9149(83)80140-4Search in Google Scholar

9. Fogelman I. et al.: A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication. J. Nucl. Med., 22, 10, 1981.Search in Google Scholar

10. Fournier C. et al.: Usefulness of technetium-99m pyrophosphate myocardial scintigraphy in amyloid polyneuropathy and correlation with echocardiography. Am. J. Cardiol., 72, 11, 1993.10.1016/0002-9149(93)91085-VSearch in Google Scholar

11. Francis M.D. et al.: Comparative evaluation of three diphosphonates: in vitro adsorption (C-14 labeled) and in vivo osteogenic uptake (Tc-99m complexed). J. Nucl. Med., 21, 12, 1980.Search in Google Scholar

12. Gertz M. et al.: Utility of technetium Tc-99m pyrophosphate bone scanning in cardiac amyloidosis. Arch. Intern. Med., 147, 6, 1987.10.1001/archinte.1987.00370060035007Search in Google Scholar

13. Glaudemans A.W. et al.: Nuclear imaging in cardiac amyloidosis. Eur. J. Nucl. Med. Mol. Imaging, 36, 4, 2009.10.1007/s00259-008-1037-119156411Search in Google Scholar

14. Grudzielanek S. et al.: Cytotoxicity of insulin within its self-assembly and amyloidogenic pathways. J. Mol. Biol., 370, 2, 2007.10.1016/j.jmb.2007.04.053Search in Google Scholar

15. Hongo M. et al.: Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation. J. Cardiogr., 15, 1, 1985.Search in Google Scholar

16. Iannuzzi C., Irace G., Sirangelo I.: The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity. Molecules, 20, 2, 2015.Search in Google Scholar

17. Jurisson S.S. et al.: Calcium affinity of coordinated diphosphonate ligands. Single-crystal structure of [(en)2Co(02P(OH)CH2P(OH)02)] ClO4.H2O. Implication for the chemistry of technetium-99mdiphosphonate skeletal imaging agents. Inorg. Chem., 22, 9, 1983.10.1021/ic00151a013Search in Google Scholar

18. Kristen A.V. et al.: Non-invasive predictors of survival in cardiac amyloidosis. Eur. J. Heart Fail., 9, 6, 2007.10.1016/j.ejheart.2007.01.012Search in Google Scholar

19. Kroesbergen J. et al.: 99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP. Int. J. Rad. Appl. Instrum. B, 15, 5, 1988.10.1016/S0969-8051(88)80002-7Search in Google Scholar

20. Kula R.W., Engel W.K., Line B.R.: Scanning for soft-tissue amyloid. Lancet, 1, 8002, 1977.Search in Google Scholar

21. Martin Jr J.L et al.: Technetium-diphosphonate skeletal imaging agents: EXAFS structural studies in aqueous solution. Inorg. Chem., 28, 15, 1989.10.1021/ic00314a001Search in Google Scholar

22. Merlini G., Bellotti V.N.: Molecular mechanisms of amyloidosis. Engl. J. Med., 349, 6, 2003.Search in Google Scholar

23. Ng B. et al.: Senile systemic amyloidosis presenting with heart failure: a comparison with light chain associated amyloidosis. Arch. Intern. Med., 165, 12, 2005.10.1001/archinte.165.12.142515983293Search in Google Scholar

24. Perugini E. et al.: Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J. Am. Coll. Cardiol., 46, 6, 2005.10.1016/j.jacc.2005.05.07316168294Search in Google Scholar

25. Pinkerton T.C. et al.: Bioinorganic activity of technetium radiopharmaceuticals. J. Chem. Educ., 62, 11, 1985.10.1021/ed062p965Search in Google Scholar

26. Puille M. et al. 99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy. Eur. J. Nucl. Med. Mol. Imaging, 29, 3, 2002.10.1007/s00259-001-0730-012002714Search in Google Scholar

27. Rapezzi C. et al.: Usefulness of 99mTc-DPD scintigraphy in cardiac amyloidosis. J. Am. Coll. Cardiol., 51, 15, 2008.10.1016/j.jacc.2007.12.03818402909Search in Google Scholar

28. Rapezzi C. et al.: Usefulness and limitations of 99mTc-3,3- diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur. J. Nucl. Med. Mol. Imaging, 38, 3, 2011.Search in Google Scholar

29. Rossi P. et al.: 99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis. Clin. Nucl. Med., 37, 8, 2012.10.1097/RLU.0b013e318248512c22785530Search in Google Scholar

30. Sipe J.D. et al.: Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid, 21, 4, 2014.10.3109/13506129.2014.96485825263598Search in Google Scholar

31. Westermark P. Subcutaneous adipose tissue biopsy for amyloid protein studies. Methods Mol. Biol., 849, 2012.10.1007/978-1-61779-551-0_2422528102Search in Google Scholar

32. Wilson G.M., Pinkerton T.C.: Determination of charge and size of technetium diphosphonate complexes by anion-exchange liquid chromatography. Anal. Chem., 57, 1, 1985.Search in Google Scholar

33. Yood R.A. et al.: Soft tissue uptake of bone seeking radionuclide in amyloidosis. J. Rheumatol., 8, 5, 1981.Search in Google Scholar